Sigyn Therapeutics, Inc.
SIGY
$4.15
$0.153.75%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 12.10K | 164.80K | 53.60K | 32.80K | 11.70K |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | 50.00K | 50.00K | 50.00K | 50.00K |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 9.10K | 54.30K | 42.70K | 51.60K | 56.40K |
| Total Current Assets | 21.20K | 269.10K | 146.40K | 134.40K | 118.10K |
|
|
|||||
| Total Current Assets | 21.20K | 269.10K | 146.40K | 134.40K | 118.10K |
| Net Property, Plant & Equipment | 121.80K | 137.60K | 153.10K | 168.20K | 183.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 70.70K | 20.70K | 20.70K | 20.70K | 20.70K |
| Total Assets | 213.70K | 427.40K | 320.20K | 323.30K | 321.80K |
|
|
|||||
| Total Accounts Payable | 608.40K | 611.60K | 488.40K | 529.50K | 461.60K |
| Total Accrued Expenses | 1.87M | 1.76M | 1.49M | 1.08M | 791.80K |
| Short-term Debt | 2.07M | 1.83M | 1.85M | 2.56M | 2.29M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 69.90K | 67.70K | 65.40K | 63.20K | 61.10K |
| Total Finance Division Other Current Liabilities | 1.70K | 0.00 | 2.20K | 2.60K | 3.20K |
| Total Other Current Liabilities | 1.70K | 0.00 | 2.20K | 2.60K | 3.20K |
| Total Current Liabilities | 4.62M | 4.28M | 3.90M | 4.23M | 3.61M |
|
|
|||||
| Total Current Liabilities | 4.62M | 4.28M | 3.90M | 4.23M | 3.61M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 2.07M | 1.83M | 1.85M | 2.56M | 2.29M |
| Capital Leases | 56.40K | 74.70K | 92.70K | 109.80K | 126.30K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 4.67M | 4.35M | 3.99M | 4.34M | 3.73M |
|
|
|||||
| Common Stock & APIC | 10.22M | 10.24M | 9.29M | 8.08M | 7.93M |
| Retained Earnings | -14.68M | -14.16M | -12.96M | -12.10M | -11.34M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -4.46M | -3.92M | -3.67M | -4.02M | -3.41M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -4.46M | -3.92M | -3.67M | -4.02M | -3.41M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -4.46M | -3.92M | -3.67M | -4.02M | -3.41M |
|
|
|||||